Results 61 to 70 of about 28,538 (266)
Dalhousie Medical Journal, 2013 Lupus erythematosus (LE) is a heterogeneous group of chronic autoimmune inflammatory diseases, ranging from solely cutaneous symptoms to systemic disease with extensive visceral involvement. 1 Lupus was first named in the Middle Ages, but evidence suggests that Hippocrates described it long before that time.
openaire +2 more sources
Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic
JEADV Clinical Practice, EarlyView.ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip +5 more
wiley +1 more source
Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case Report
JEADV Clinical Practice, EarlyView.ABSTRACT Reticular erythematous mucinosis is a rare dermatosis with a challenging diagnosis. To date, its dermoscopic features have not been well characterised in the literature. Only a limited number of case reports have described dermoscopic findings that may be indicative of the disorder, including the presence of dotted and linear vessels, as well ...
Grażyna Kamińska‐Winciorek +4 more
wiley +1 more source
Subacute Cutaneous Lupus Erythematosus: A Paraneoplastic Dermatosis in Breast Carcinoma?
, 2021 selma bekar dertlioglu
openalex +1 more source
Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study
JEADV Clinical Practice, EarlyView.ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru +13 more
wiley +1 more source
Gazi Medical JournalTumid lupus erythematosus is an uncommon subtype of chronic cutaneous lupus erythematosus. Hereby, we report a 36-year-old male patient with tumid lupus erythematosus who presented with erythematous papules and plaques on the face and neck who showed ...
Funda Tamer +3 more
doaj +1 more source
Associação entre lúpus eritematoso e tabagismo Association between lupus erythematosus and smoking
Anais Brasileiros de Dermatologia, 2008 FUNDAMENTOS: O lúpus eritematoso é doença crônica, auto-imune, que reúne manifestações exclusivamente cutâneas ou multissistêmicas, caracterizada pela produção de auto-anticorpos contra vários constituintes celulares.
Júnia Maria Fernandes Araújo +4 more
doaj +1 more source
Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
Rare Metals, EarlyView.ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan +5 more
wiley +1 more source
Topical calcineurin inhibitors in systemic lupus erythematosus
Therapeutics and Clinical Risk Management, 2010 Christos E Lampropoulos, David P D’CruzLupus Research Unit, Rayne Institute, St. Thomas’ Hospital, London, UKAbstract: Cutaneous lupus erythematosus (CLE) encompasses a variety of lesions that may be refractory to systemic or topical ...
Christos E Lampropoulos +1 more
doaj
Journal of Medical Case Reports, 2011 Introduction The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly used in the treatment of several malignant tumors. The usual side effects of this drug are hypertension and proteinuria. Paclitaxel is widely used in
Koulu Leena +4 more
doaj +1 more source